
    
      This study will use a multi-center, open-label study design in subjects with onychomycosis of
      at least one great toenail to assess the safety, local tolerability, and efficacy of chronic
      daily ungual application of EcoNailâ„¢. Forty (40) evaluable subjects will apply study drug
      daily to at least one affected great toenail for 48 weeks. The subjects must comply with all
      inclusion and exclusion criteria.
    
  